IOM study calls for better evidence for biomarker tests

Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine.

Pietenpol named to IOM Cancer Policy Forum

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies.

Moses to receive Vanderbilt Distinguished Alumni Award

Harold “Hal” Moses, the Hortense B. the Ingram Professor of Cancer Research at Vanderbilt University, is the recipient of the 2014 Distinguished Alumni Award — the highest honor for a member of the Vanderbilt alumni community.

More resources needed to fight sex trafficking

Efforts to prevent, identify and respond to children and adolescents who are victims of commercial sexual exploitation and sex trafficking are largely under supported, inefficient, uncoordinated and unevaluated, according to a report released last week by a committee of the Institute of Medicine (IOM).

Campus aerials. (John Russell/Vanderbilt University)

Beauchamp, Vermund elected to Institute of Medicine

R. Daniel Beauchamp, M.D., chair of the Section of Surgical Sciences, and Sten Vermund, M.D., Ph.D., director of the Vanderbilt Institute for Global Health, have been elected to the Institute of Medicine (IOM), the organization announced this week.

Buerhaus named to Institute of Medicine’s GME committee

Peter Buerhaus, Ph.D., R.N., has been named to the Institute of Medicine’s Committee for Governance and Financing of Graduate Medical Education.